GSK3B and cardiac hypertrophy: Moreover, miR-199a (80), miR-26 (81), miR-378 (82), miR-29c-3p, miR-144-3p, miR-195a-3p (83), and miR-126 (84) were reported to target GSK3β in direct or indirect manners during the occurrence and development of pathological cardiac hypertrophy, respectively.